Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2018-03-22

Clinical Trial Update: Adriamycin, Vinblastine, DTIC and Revlimid in Elderly Hodgkin Lymphoma Patients [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating a four-drug combination (doxorubicin, vinblastine, dacarbazine, and lenalidomide) in elderly patients with Hodgkin lymphoma; the stud…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Adriamycin (doxorubicin)
  • DTIC (dacarbazine)
  • Revlimid (lenalidomide)
  • Vinblastine (vinblastine)

Snippet

Sponsor: University of Cologne | Conditions: Hodgkin Lymphoma | Phase 1 | Status: COMPLETED